Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for Diabetes in Youth study
- PMID: 36868256
- PMCID: PMC10091237
- DOI: 10.1016/S2213-8587(23)00025-6
Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for Diabetes in Youth study
Abstract
Background: The incidence of diabetes is increasing in children and young people. We aimed to describe the incidence of type 1 and type 2 diabetes in children and young people aged younger than 20 years over a 17-year period.
Methods: The SEARCH for Diabetes in Youth study identified children and young people aged 0-19 years with a physician diagnosis of type 1 or type 2 diabetes at five centres in the USA between 2002 and 2018. Eligible participants included non-military and non-institutionalised individuals who resided in one of the study areas at the time of diagnosis. The number of children and young people at risk of diabetes was obtained from the census or health plan member counts. Generalised autoregressive moving average models were used to examine trends, and data are presented as incidence of type 1 diabetes per 100 000 children and young people younger than 20 years and incidence of type 2 diabetes per 100 000 children and young people aged between 10 years and younger than 20 years across categories of age, sex, race or ethnicity, geographical region, and month or season of diagnosis.
Findings: We identified 18 169 children and young people aged 0-19 years with type 1 diabetes in 85 million person-years and 5293 children and young people aged 10-19 years with type 2 diabetes in 44 million person-years. In 2017-18, the annual incidence of type 1 diabetes was 22·2 per 100 000 and that of type 2 diabetes was 17·9 per 100 000. The model for trend captured both a linear effect and a moving-average effect, with a significant increasing (annual) linear effect for both type 1 diabetes (2·02% [95% CI 1·54-2·49]) and type 2 diabetes (5·31% [4·46-6·17]). Children and young people from racial and ethnic minority groups such as non-Hispanic Black and Hispanic children and young people had greater increases in incidence for both types of diabetes. Peak age at diagnosis was 10 years (95% CI 8-11) for type 1 diabetes and 16 years (16-17) for type 2 diabetes. Season was significant for type 1 diabetes (p=0·0062) and type 2 diabetes (p=0·0006), with a January peak in diagnoses of type 1 diabetes and an August peak in diagnoses of type 2 diabetes.
Interpretation: The increasing incidence of type 1 and type 2 diabetes in children and young people in the USA will result in an expanding population of young adults at risk of developing early complications of diabetes whose health-care needs will exceed those of their peers. Findings regarding age and season of diagnosis will inform focused prevention efforts.
Funding: US Centers for Disease Control and Prevention and US National Institutes of Health.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Figures



Comment in
-
SEARCHing for answers to youth-onset type 2 diabetes.Lancet Diabetes Endocrinol. 2023 Apr;11(4):219-220. doi: 10.1016/S2213-8587(23)00037-2. Epub 2023 Feb 28. Lancet Diabetes Endocrinol. 2023. PMID: 36868255 No abstract available.
Similar articles
-
Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.N Engl J Med. 2017 Apr 13;376(15):1419-1429. doi: 10.1056/NEJMoa1610187. N Engl J Med. 2017. PMID: 28402773 Free PMC article.
-
Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.JAMA. 2014 May 7;311(17):1778-86. doi: 10.1001/jama.2014.3201. JAMA. 2014. PMID: 24794371 Free PMC article.
-
The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study.Pediatrics. 2006 Oct;118(4):1510-8. doi: 10.1542/peds.2006-0690. Pediatrics. 2006. PMID: 17015542
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
The SEARCH for Diabetes in Youth study: rationale, findings, and future directions.Diabetes Care. 2014 Dec;37(12):3336-44. doi: 10.2337/dc14-0574. Diabetes Care. 2014. PMID: 25414389 Free PMC article. Review.
Cited by
-
Mitogen-Activated Protein Kinase Phosphatase-2 Deletion Promotes Hyperglycemia and Susceptibility to Streptozotocin-Induced Diabetes in Female Mice In Vivo.Cells. 2025 Feb 12;14(4):261. doi: 10.3390/cells14040261. Cells. 2025. PMID: 39996734 Free PMC article.
-
Establishing Screening Programs for Presymptomatic Type 1 Diabetes: Practical Guidance for Diabetes Care Providers.J Clin Endocrinol Metab. 2025 Jul 15;110(8):2371-2382. doi: 10.1210/clinem/dgaf194. J Clin Endocrinol Metab. 2025. PMID: 40171881 Free PMC article.
-
Exploring the Diagnostic Complexity of Diabetes Subtypes in Pediatric Obesity: A Case Report of an Adolescent With Prader-Willi Phenotype and Literature Review.Cureus. 2024 Aug 8;16(8):e66456. doi: 10.7759/cureus.66456. eCollection 2024 Aug. Cureus. 2024. PMID: 39135667 Free PMC article.
-
Longitudinal study on metabolic abnormalities and diabetes risk in normal-weight japanese adults.Front Endocrinol (Lausanne). 2024 Aug 29;15:1445934. doi: 10.3389/fendo.2024.1445934. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39268236 Free PMC article.
-
Clinical Features and HLA Genetics Differ in Children at Type 1 Diabetes Onset by Hispanic Ethnicity.J Clin Endocrinol Metab. 2025 Mar 17;110(4):1187-1194. doi: 10.1210/clinem/dgae608. J Clin Endocrinol Metab. 2025. PMID: 39231249 Free PMC article.
References
-
- Zylke JW, DeAngelis CD. Pediatric chronic diseases—stealing childhood. JAMA 2007;297:2765–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical